OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adrenal Ablation Versus Mineralocorticoid Receptor Antagonism for the Treatment of Primary Aldosteronism: A Single-Center Prospective Cohort Study
Yaqiong Zhou, Qiting Liu, Xinquan Wang, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 1014-1023
Open Access | Times Cited: 13
Yaqiong Zhou, Qiting Liu, Xinquan Wang, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 1014-1023
Open Access | Times Cited: 13
Showing 13 citing articles:
The application value of ipsilateral superselective adrenal arteriography and adrenal venography in patients with primary aldosteronism undergoing adrenal artery embolization
Sen L, Xinquan Wang, Peijian Wang
Hypertension Research (2025)
Closed Access
Sen L, Xinquan Wang, Peijian Wang
Hypertension Research (2025)
Closed Access
A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism
Yaqiong Zhou, Xinquan Wang, Jixin Hou, et al.
Hypertension Research (2023)
Closed Access | Times Cited: 9
Yaqiong Zhou, Xinquan Wang, Jixin Hou, et al.
Hypertension Research (2023)
Closed Access | Times Cited: 9
The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study
Ze-Qun Lai, Yang Fu, Jianwei Liu, et al.
Hypertension Research (2023) Vol. 47, Iss. 4, pp. 944-958
Closed Access | Times Cited: 8
Ze-Qun Lai, Yang Fu, Jianwei Liu, et al.
Hypertension Research (2023) Vol. 47, Iss. 4, pp. 944-958
Closed Access | Times Cited: 8
Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study
Guo Ji, Changqiang Yang, Jixin Hou, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 200-211
Closed Access | Times Cited: 2
Guo Ji, Changqiang Yang, Jixin Hou, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 200-211
Closed Access | Times Cited: 2
The outcomes of transcatheter adrenal ablation in patients with primary aldosteronism: a systematic review and meta-analysis
Shunfan Yang, Guoliang Wang, Nanfang Li, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Shunfan Yang, Guoliang Wang, Nanfang Li, et al.
BMC Endocrine Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Unilateral chemical ablation of the adrenal gland lowers blood pressure and alleviates target organ damage in spontaneously hypertensive rats
Xinquan Wang, T. Luo, Yi Yang, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2693-2704
Closed Access | Times Cited: 2
Xinquan Wang, T. Luo, Yi Yang, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2693-2704
Closed Access | Times Cited: 2
Accumulating evidence suggests the potential of selective adrenal artery embolization as a standard treatment for primary aldosteronism
Toshifumi Nakamura, Kaori Hayashi
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1744-1746
Open Access
Toshifumi Nakamura, Kaori Hayashi
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1744-1746
Open Access
The application of superselective adrenal artery embolization in primary aldosteronism: evaluation, challenges, and response to Mr. Cabrelle and his team
Ze-Qun Lai, Yifei Dong
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1755-1758
Closed Access
Ze-Qun Lai, Yifei Dong
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1755-1758
Closed Access
Establishment of a scoring model for predicting clinical outcomes in patients with unilateral primary aldosteronism after superselective adrenal artery embolization
T. Luo, Jindong Wan, Sen L, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 5, pp. 2269-2279
Closed Access
T. Luo, Jindong Wan, Sen L, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 5, pp. 2269-2279
Closed Access
Efficacy and safety of adrenal arterial embolization for primary aldosteronism: a systematic review and meta-analysis
Sen Fu, Wenchao Xu, Tao Wang, et al.
Gland Surgery (2024) Vol. 13, Iss. 6, pp. 825-832
Open Access
Sen Fu, Wenchao Xu, Tao Wang, et al.
Gland Surgery (2024) Vol. 13, Iss. 6, pp. 825-832
Open Access
Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study
Min Mao, Rui Feng, Nouman Khan, et al.
BMC Surgery (2024) Vol. 24, Iss. 1
Open Access
Min Mao, Rui Feng, Nouman Khan, et al.
BMC Surgery (2024) Vol. 24, Iss. 1
Open Access
Adrenal arterial embolization: a possible new treatment for patients with primary aldosteronism
Kenichi Yokota
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 358-360
Open Access | Times Cited: 1
Kenichi Yokota
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 358-360
Open Access | Times Cited: 1
Lowering of blood pressure by chemical ablation of the unilateral adrenal gland in spontaneously hypertensive rats
Satoshi Morimoto, Atsuhiro Ichihara
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 551-552
Open Access
Satoshi Morimoto, Atsuhiro Ichihara
Hypertension Research (2023) Vol. 47, Iss. 2, pp. 551-552
Open Access
